Related Experiment Videos
Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation
T Bienvenu1, V des Portes, N McDonell
1Institut National de la Santé et de la Recherche Médicale U129-ICGM, Faculté de Médecine Cochin, Paris, France. bienvenu@cochin.inserm.fr
American Journal of Medical Genetics
|August 18, 2000
Summary
Researchers identified a new mutation in the PAK3 gene (R67C) linked to X-linked mental retardation (MRX) in a large family. This finding reinforces PAK3
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- X-linked mental retardation (MRX) affects about 1 in 600 males, with underlying genetic causes often unknown.
- Recent studies suggest mutations in the PAK3 gene are associated with non-specific mental retardation.
- PAK3 protein plays a role in linking cellular signaling pathways to the cytoskeleton.
Purpose of the Study:
- To investigate the role of the PAK3 gene in X-linked mental retardation.
- To screen for mutations in the PAK3 gene in families with MRX.
Main Methods:
- Screening of 12 MRX pedigrees mapping to Xq21-q24.
- Mutation analysis of the entire coding region of the PAK3 gene using denaturing gradient gel electrophoresis and direct sequencing.
Main Results:
- A novel missense mutation, R67C, was identified in exon 2 of the PAK3 gene in the MRX47 family.
- This mutation is located in a conserved domain crucial for PAK3 protein activity.
- Affected males in the MRX47 family exhibit moderate to severe mental retardation without other significant physical abnormalities.
Conclusions:
- The study confirms the involvement of PAK3 in X-linked mental retardation.
- The identified R67C mutation provides further evidence for PAK3 as a key gene in MRX pathogenesis.
- Understanding these genetic defects is crucial for diagnosing and potentially treating MRX disorders.